Who we are

At Callisto BioMed, we are scientists, clinicians, engineers, and innovators united by a single mission: to advance the science of diagnostics and empower earlier, more precise decisions in cardiovascular care.

We believe that critical insights are hiding in plain sight, within the complexity of lipoprotein biology, and that conventional testing methods often fail to capture what truly matters. That’s why we’ve built a new approach from the ground up.

A New Standard in Diagnostics

Our team brings together decades of experience in:

• Cardiovascular research

• Clinical diagnostics

• Microfluidics and lab automation

• Regulatory science and commercialization

Together, we’ve developed a microfluidic platform capable of resolving HDL and LDL subfractions with clinical-grade precision—bringing advanced lipid profiling into real-world practice.

Focused on What Matters

We don’t just generate data—we translate complex lipoprotein biology into clear, actionable insights.

By measuring clinically validated markers like HDL2b, HDL3, and small dense LDL (sdLDL), our tests help providers move beyond “good vs. bad cholesterol” and into a new era of personalized cardiovascular prevention.

Our Vision

We envision a future where diagnostics are:

• More precise

• More predictive

• More accessible

From cardiovascular disease to metabolic and inflammatory conditions, Callisto BioMed is committed to driving that transformation - one test at a time.